Division of Maternal-Fetal Medicine and the Department of Psychiatry and Behavioral Health, The Ohio State University, Columbus, Ohio.
Obstet Gynecol. 2024 Jun 1;143(6):815-818. doi: 10.1097/AOG.0000000000005572. Epub 2024 Apr 4.
Buprenorphine is commonly used as a treatment for opioid use disorder (OUD). Transition to buprenorphine traditionally has been done using a low-dose initiation regimen due to concerns surrounding precipitated withdrawal. There are increasing data supporting use of a high-dose initiation regimen in the nonpregnant population. This retrospective case series describes six individuals with OUD who underwent high-dose buprenorphine initiation in pregnancy. There were no instances of sedation, respiratory depression, supplemental oxygen use, or death. All individuals were successfully transitioned to buprenorphine. These findings provide support for high-dose buprenorphine initiation in pregnancy, but future large studies are needed.
丁丙诺啡通常被用作阿片类药物使用障碍(OUD)的治疗方法。由于担心引发戒断,传统上采用低剂量起始方案来过渡到丁丙诺啡。越来越多的数据支持在非孕妇人群中使用高剂量起始方案。本回顾性病例系列描述了 6 例在妊娠期间接受高剂量丁丙诺啡起始治疗的 OUD 患者。没有镇静、呼吸抑制、使用补充氧气或死亡的情况。所有患者均成功过渡到丁丙诺啡。这些发现为妊娠期间高剂量丁丙诺啡起始提供了支持,但需要进一步开展大型研究。